active surveillance 2021 (part 3) - patient selection, monitoring, and innocuous interventions
Published 3 years ago • 2.6K plays • Length 20:44Download video MP4
Download video MP3
Similar videos
-
1:58
integrated diagnostics and patient selection for active surveillance and treatment
-
20:50
active surveillance 2021 - from bench to bedside
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
11:13
active surveillance in favorable intermediate-risk prostate cancer
-
28:33
active surveillance results and implications of prospective studies
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
22:08
3 4=7 #prostatecancer | active surveillance vs. focal therapy | #markscholzmd #alexscholz #pcri
-
15:48
active surveillance for prostate cancer
-
19:55
gleason 3 4 prostate cancer
-
29:23
how should we monitor patients during surveillance?
-
9:15
point-counterpoint: active surveillance for intermediate-risk prostate cancer - pro
-
23:37
active surveillance who is the right patient and what is the right protocol
-
24:04
active surveillance or focal therapy as primary management
-
20:23
active surveillance criteria and follow-up protocol
-
1:47
dr. loblaw on using active surveillance to monitor men with intermediate-risk prostate cancer
-
49:07
active surveillance with dr. laurence klotz - zero prostate cancer summit 2022
-
45:27
5.27.2020 urology covid didactics - active surveillance for early stage prostate cancer
-
2:40
ask the expert: how often should patients on active surveillance be biopsied and imaged?
-
1:03:23
weill cornell urology - grand rounds: dr. herbert lepor
-
9:14
prostate cancer active surveillance in 2019
-
4:43
active surveillance - watchful waiting for prostate cancer | ucla urology - dr. leonard marks
-
9:27
role of mr-targeted prostate biopsy in active surveillance